The Quiet Campaign for Genetically Engineered Humans
By Richard Hayes,
Earth Island Journal, Spring 2001
| 11. 30. 2000
We are fast approaching the most consequential technological threshold in all of human history: the ability to directly manipulate the genes we pass on to our children.
Development and use of these technologies would irrevocably change the nature of human life and human society. It would destabilize human biological identity and function. It would put into play a wholly unprecedented set of social, psychological and political forces that would feed back upon themselves with impacts quite beyond our ability to imagine, much less control.
These technologies are being developed and promoted by an influential network of scientists who see themselves ushering in a new epoch for human life on Earth. They look forward to the day when parents can quite literally assemble their children from genes listed in a catalog. They celebrate a future in which our common humanity is lost as a genetically enhanced elite increasingly acquires the attributes of a separate species.
There is little public awareness of the full implications of the new human genetic engineering (HGE) technologies or of the campaign to promote them. There are...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...